Research reference only — not a catalog item
Livagen
Research context
The synthetic peptide Livagen was applied to lymphocytes from older adults, and ribosomal-gene activity and heterochromatin condensation were the recorded endpoints.
What has been studied
- Human lymphocytes
- Chromatin assays
Khavinson et al. (2002) applied the synthetic peptide Livagen to lymphocytes from older adults and recorded ribosomal-gene activity and heterochromatin condensation. The cited work is a lymphocyte study.
These labels restate the setting of the cited paper. They are not new findings and do not describe a catalog material.
Research model areas
- Lymphocytes from older adults
- Ribosomal-gene and heterochromatin assays
Selected published literature
What remains uncertain
Limitations
These lymphocyte measurements do not establish an immune or aging application in people.
Model areas in the Body Explorer: Immune signaling models.